Connect with us

Cannabis News

50% of All Cannabis Users Have ADHD?



half of marijuana users have ADHD

Do Half of All Marijuana Users Have ADHD? Unpacking the Claims and Community Response


The prevalence of Attention Deficit Disorder (ADD) and Attention Deficit Hyperactivity Disorder (ADHD) stands as a focal point of contemporary discussions. These conditions, characterized by symptoms such as inattention, hyperactivity, and impulsivity, continue to garner significant interest from both medical professionals and the general public. To set the stage for our exploration, let’s start by considering the current statistics of ADD/ADHD diagnoses. How widespread are these conditions, and what percentage of the population is navigating the challenges they present?


Parallel to this, the world of cannabis consumption is undergoing its own evolution. The question of how many people regularly use marijuana in the United States is not just a matter of cultural interest but also of public health and policy. Recent data sheds light on the shifting landscape of cannabis use, revealing trends that intersect with various aspects of society, including mental health.


Into this intersection of mental health and cannabis use enters a provocative claim from, a platform dedicated to ADD/ADHD awareness and support. The website posits that half of all cannabis users have ADD or ADHD, a statement that, if true, would have profound implications for understanding the relationship between these disorders and marijuana use. In this article, we delve into this claim, examining its factual basis and the responses it has elicited from the cannabis community, particularly through a vibrant Reddit discussion. Our journey will navigate the intricacies of this assertion, seeking clarity amidst a sea of anecdotes and data.



In the intricate web of health, psychology, and substance use, certain claims stand out for their boldness and potential implications. One such claim, coming from the digital corridors of AdditudeMag, asserts that a staggering 50% of cannabis users are grappling with ADD or ADHD. This assertion, if proven true, could significantly alter our understanding of the relationship between cannabis consumption and these prevalent neurological disorders.


To unravel this claim, let’s dissect the underpinnings of AdditudeMag’s argument. The website, known for its focus on ADD and ADHD, brings forth a set of supporting clauses that merit closer inspection. However, a critical eye must be cast on the nature of these clauses – are they based on comprehensive research, or do they stem from a place of internal bias, skewed towards a particular narrative?


Delving into the content, it becomes apparent that AdditudeMag has a tendency to cherry-pick topics that reinforce a certain viewpoint. The studies they reference, and the manner in which they interpret these studies, raise questions about the scientific robustness of their claims. For instance, one might argue that the website leans heavily on anecdotal evidence or selects research findings that specifically align with their perspective, potentially overlooking a broader scientific consensus or contradictory data.


To validate or debunk their assertions, we must turn to the quoted material directly from their website. However, in the absence of a clear, scientific consensus and given the complexity of the relationship between cannabis use and ADHD, it’s challenging to unequivocally affirm or refute their stance. This ambiguity leaves room for further research and a more nuanced understanding of the interplay between cannabis and neurological conditions like ADHD.


Furthermore, the tone and subject matter of AdditudeMag’s content may inadvertently reflect an internal bias. While their focus on ADHD-related topics is understandable given their specialization, it’s crucial to question whether this focus leads to a myopic view of the broader health implications of cannabis use. Are they adequately considering the multifaceted nature of cannabis consumption, including its varied effects on different individuals and the diverse reasons people turn to it?


While the claim that half of cannabis users have ADD or ADHD is provocative, the current evidence and methodologies employed in supporting this claim require a more critical examination. The scientific community’s ongoing efforts to understand the complexities of cannabis and its impact on neurological conditions will undoubtedly shed more light on this intriguing intersection in the future. So for now, let’s simply say that it’s “not proven to be true”.




The vibrant community of cannabis enthusiasts on Reddit offers a wealth of perspectives on the relationship between marijuana use and ADHD. These candid insights provide a more nuanced view of the varied experiences of individuals who use cannabis, some with ADHD and others without. Let’s delve into a selection of these comments to understand this dynamic better.


Seattlehepcat comments, “With weed, I can focus, but in a more mellow way than the Ritalin.” This sentiment resonates with many users who find cannabis a gentler alternative to traditional ADHD medications. The concept of achieving focus in a less intense manner seems to appeal to those who might otherwise struggle with the side effects of stimulant drugs.


Thisisntmyaccount24 shares a reflection on stereotypes, stating, “It’s funny that the ‘stoner’ stereotype back in the day was a person with essentially a slowed-down brain. As someone with ADHD and anxiety, that is what I am going for a lot of the time.” This observation underlines the irony in how cannabis, often associated with cognitive slowing, can paradoxically aid individuals in managing their hyperactive minds.


Another user, PussyWax, humorously compares using cannabis to “putting blinders on a horse before a two-hour history lecture,” highlighting its ability to narrow focus. This analogy aptly captures how some individuals with ADHD use cannabis to filter out distractions and hone their concentration.


Amid these personal accounts, it’s crucial to address the factual accuracy of AdditudeMag’s claim that half of all cannabis users have ADD or ADHD. While anecdotal evidence suggests that individuals with ADHD may self-medicate at a higher rate, there is no solid user data to support the notion that 50% of all cannabis users have ADD. Such a sweeping generalization does not hold up under scientific scrutiny. It’s more likely that this figure emerged from a subjective analysis rather than a peer-reviewed study, underscoring the need for more comprehensive research in this area.


These Reddit comments paint a vivid picture of the diversity within the cannabis community. They remind us that while some individuals find cannabis helpful for managing ADHD symptoms, others enjoy it for entirely different reasons, challenging the oversimplified narratives often presented in discussions about cannabis use.



In the intricate dance of data interpretation and narrative construction, there’s a thin line between enlightenment and deception. This line becomes especially significant when discussing complex topics like cannabis use and its association with conditions like ADHD. The art of “lying with statistics” is not just a cunning play of numbers; it’s about framing questions and interpreting data in ways that craft a specific narrative, often serving hidden agendas.


Historically, the government has been accused of “weaponizing science” in its approach to cannabis research. A striking example of this is the infamous monkey experiment that purported to show cannabis causing brain damage. In this study, monkeys were subjected to such high levels of cannabis smoke that they essentially suffocated. This methodological flaw led to misleading conclusions about cannabis destroying brain cells, which were later debunked as a hoax. Yet, for a time, this “research” was wielded as a scientific weapon against cannabis legalization.


This historical context makes one cautious about accepting claims without rigorous scrutiny. The assertion that half of all cannabis users have ADD or ADHD, while not inherently implausible, demands a critical evaluation. It’s essential to differentiate between genuinely insightful studies and those that might be tailored to propagate a particular viewpoint. In the absence of peer-reviewed data substantiating this claim, its credibility remains questionable.


The cannabis community, diverse in its composition and motivations, cannot be accurately represented through a singular lens. The vast array of reasons for cannabis use – from therapeutic to recreational – defies reduction to a single statistic. It’s imperative, therefore, to approach such claims with a healthy dose of skepticism, demanding robust, peer-reviewed research that acknowledges the complexity of cannabis use and its multifaceted impact on individuals’ lives.



In the hazy intersection of cannabis use and ADHD, certain truths emerge with clarity from the smoke. A significant number of individuals with ADD or ADHD express a preference for cannabis over conventional prescription medications. This inclination towards self-medication with marijuana underscores a broader narrative – one where individuals with ADHD find solace in the plant’s natural properties, often more attuned to their needs than the effects of traditional pharmaceuticals.


This trend doesn’t just highlight a personal choice; it signals a pressing need for deeper, more nuanced research into cannabis and its potential as a therapeutic agent, especially for ADHD. Imagine a future where cannabis-based medications are specifically tailored for ADHD, harnessing the plant’s benefits while minimizing any drawbacks. Such a prospect isn’t just wishful thinking; it’s a call to action for the scientific community to explore and develop cannabis-based treatments that could revolutionize how we approach ADD/ADHD management.


As we stand at the crossroads of understanding and innovation, the path forward is clear: more research, more empathy, and a willingness to embrace the potential of cannabis in transforming the lives of those with ADHD.





Source link

Cannabis News

Australia Cannabis: Recreational Use Legislation Update




Australia is said to have one of the highest cannabis prevalence rates in the world and public attitudes to its use are shifting. North American, European and other cannabis companies looking for investment opportunities would do well to follow these shifts.

Growing cannabis for medicinal and scientific purposes was legalized under federal law in 2016. Low-THC hemp foods were then legalized federally in 2017. Recreational use, though, remains prohibited under federal law. Similarly, at the state and territory level it is mostly illegal to use, possess, grow, and sell cannabis. Despite these continuing prohibitions, there are legislative trends toward legalization.

If passed, the Legalising Cannabis Bill 2023 would change the federal landscape. It would legalize cannabis for adult recreational use in Australia. The Bill would establish the Cannabis Australia National Agency as a statutory agency to register cannabis strains and regulate cannabis activities. These activities include growing and possessing plants, manufacturing and selling cannabis products, operating cannabis cafes, and importing and exporting cannabis products.

The Senate Legal and Constitutional Affairs Committee is presently conducting an inquiry into the Bill. Submissions have now closed and public hearings have opened. The Committee’s reporting date is May 31, 2024. The Bill is expected to be debated in federal parliament later this year. At the same time, cannabis legalization bills are now being debated in several Australian states.

Despite shifting public attitudes, federal legalization may still be a way off. While the federal Bill has been promoted by a minority party, it does not enjoy the support of the ruling party or the major opposition party. It also lacks the support of the Australian Medical Association.

Stay tuned for updates on Legalising Cannabis Bill 2023 and all thing Australian cannabis. And please reach out to us if you are interested in doing business in Australia.

Source link

Continue Reading

Cannabis News

Why Is Everyone Suddenly Eating Magic Mushrooms and Having Wild Sex?




magic mushrooms and sex

New Study Reveals That Magic Mushroom Consumers Have Better Sex Lives

Magic mushrooms have been on a heyday, thanks to the numerous health and therapeutic benefits it has been proven to offer. These include, but are not limited to: treating anxiety and depression, PTSD, OC, suicidal thoughts, and other mental illnesses.

However, we’re only starting to discover the myriad of benefits that the humble magic mushroom has. Now, there’s even new science suggesting that psilocybin can help improve sex lives.


In what is believed to be the first-ever study to delve deeper into the connections between sex and arousal with magic mushrooms, researchers have discovered fascinating findings. Investigators at the Imperial College London surveyed almost 300 individuals before and after taking magic mushrooms. They focused on two subject groups: individuals who consumed psychedelics for recreation or wellness, and those who were consuming it for clinical study purposes to analyze its impacts on depression. Thanks to the data, they were able to pull incredible insight into the link between sex and psychedelic experiences.

The data shows that on average, there are improvements on several areas pertaining to sexual function for as long as 6 months after psychedelic experiences. Psychedelic consumption has been shown to positively impact arousal, sexual satisfaction, enjoyment, self-esteem, connection, communication, and attraction to one’s partner – all of which contribute to better sex lives. For the group who were taking magic mushrooms as part of a clinical trial for depression, nearly half experienced improvements when it came to interest in sex, satisfaction, and arousal. In contrast, individuals who are treated with popular pharmaceutical antidepressants usually say that their sex lives are negatively impacted.


“We believe this is the first scientific study to explore the effects of psychedelics on sexual functioning. Our findings suggest potential implications for conditions that negatively affect sexual health, including clinical depression and anxiety,” said Tomasso Barba, the study’s first author, and a PhD candidate at the Centre for Psychedelic Research.


“This is particularly significant given that sexual dysfunction, often induced by antidepressants, frequently results in people stopping these medications and subsequently relapsing,” they added.  

In addition, it’s nothing short of fascinating that the results showed that the improvements in sexual function were observed for up to 6 months among some participants. However, it’s important to note they didn’t study performance while high on the drug, which is how many people on psychedelics experiment with sex: while on magic mushrooms.


“It’s important to stress our work does not focus on what happens to sexual functioning while people are on psychedelics, and we are not talking about perceived ‘sexual performance’,   they emphasized.


They do call for more studies on the subject. “While the findings are indeed interesting, we are still far from a clear clinical application, because psychedelics are yet to be integrated into the medical system. In future, we may be able to see a clinical application, but more research is needed,” said Dr. David Erritzoe.


Can Psychedelics Unlock The Key To Better, More Satisfying Sex?

As millions of us are plagued by mental health disorders, ranging from everyday anxiety to more severe depression, our sex lives will naturally suffer.

It is known that for many of us, especially women, mental health is critical to sexual satisfaction and pleasure. Sure, it’s an integral part of being human – experiencing sexual joy and arousal, but when we’re suffering from hard-to-treat mental conditions, it can be difficult to enjoy sex. Perhaps that’s where the potential of psychedelics, such as magic mushrooms, come in.


When one is struggling with family conditioning, previous traumas, depression, and self-acceptance, pleasure can be shameful and even painful to even address. But psychedelics can help open us up mentally, and challenge past thoughts that have to do with social conditioning, receiving love and pleasure. All in all, psychedelics can help create new mental pathways that make it easier for us to receive pleasure.


These days, it’s no longer uncommon for couples to medicate with psychedelics together. And we don’t just mean magic mushrooms: MDMA, LSD, and ayahuasca are other forms of healing psychedelics that can help couples work through their own traumas and issues together, and as a result, enjoy better sex.


In another study from 2021, researchers utilized interviews to conduct a qualitative study to understand the impact of microdosing MDMA on male and female couples whose ages ranged from 20 to 35 years old. The interview questions were focused on how microdosing psychedelics affected their sexuality, confidence, relationship satisfaction, inhibition, and openness.

The participants reported that microdosing did indeed have a positive effect on sexual well-being as well as other aspects, most especially because of its ability to reduce anxiety and stress. As a result, they experienced heightened sexual pleasure, desire, and communication. Overall, they reported better sex and they attributed it to microdosing.




Aside from these studies, psychedelics are already an accepted tool for young people all around the world to help them improve many aspects of their lives, including sex. It is becoming clear that the ability of psychedelics to help where pharmaceutical medications fail in treating everyday mental illnesses and stress that hinder sex lives, can transform how we relate, show up, and communicate in our intimate relationships. We hope to see more studies on the subject so we can learn more about the specifics involved, and the magic that psychedelics brings into human lives.





Source link

Continue Reading

Cannabis News

How Can Cops Tell the Difference Between Hemp and Marijuana?




police test for hemp or cannabis

Researchers funded by the federal government have unveiled novel techniques for distinguishing between marijuana and hemp by precisely measuring the THC levels in both flowers and edibles.


The National Institute of Justice (NIJ), a branch of the Justice Department, is championing the findings from two research endeavors it sponsored, focusing on refining cannabis lab testing. These findings are being disseminated to specific law enforcement agencies.


The primary goal of these projects was to streamline testing procedures to address the increasing backlog in crime labs, exacerbated by the federal legalization of hemp with THC levels of up to 0.3 percent under the 2018 Farm Bill. This legalization has complicated cannabis-related cases.


According to a recent update by NIJ, existing testing methods fall short of accurately quantifying THC levels in samples. However, the researchers supported by NIJ have made a breakthrough by utilizing two distinct forms of mass spectrometry—gas chromatography-mass spectrometry (GC-MS) and direct analysis in real time-high-resolution mass spectrometry (DART-HRMS)—to isolate THC content, along with other cannabinoids.


Pioneering Techniques


The GC-MS methodology was pioneered by a team at the National Institute of Standards and Technology (NIST), enabling them to extract THC from samples and conduct precise cannabinoid content analysis. The Department of Justice (DOJ) initially disclosed in 2020 its allocation of $350,000 in funding to NIST for this research endeavor.


Conversely, the DART-HRMS approach presents a solution to another complexity in cannabis testing encountered in forensic laboratories. This method facilitated the determination of THC levels in various products such as baked goods, candies, beverages, and plant materials with minimal pre-treatment requirements.


Rabi Musah, the primary researcher on the DART-HRMS team, envisions that the accelerated utilization of DART-HRMS for THC detection in cannabis samples could mitigate testing backlogs, reduce chemical reagent expenses, and streamline analysis protocols, as noted by NIJ.


NIST’s GC-MS technique has already catalyzed the development of new standard operating procedures for laboratories, with outcomes integrated into training procedures for law enforcement entities like the Montgomery County Police Department and Maryland State Police.


Furthermore, in 2022, U.S. Customs and Border Protection (CBP) issued a call for portable marijuana analyzers to expedite cannabinoid profile identification and aid in differentiating between marijuana and hemp.


In a separate initiative, the Drug Enforcement Administration (DEA) announced in 2019 its pursuit of a device capable of distinguishing between hemp and marijuana, particularly since the legalization of the former crop.


The ramifications of hemp legalization became evident in Texas, where marijuana possession arrests decreased by nearly 30% from 2018 to 2019 after the state legalized the non-intoxicating cannabis crop. Subsequently, prosecutors in Texas dismissed numerous low-level cannabis cases following hemp legalization. In 2020, officials announced that laboratories would no longer conduct testing in misdemeanor cases, citing capacity limitations within the Department of Public Safety.


Meanwhile, stakeholders in the hemp industry and agricultural officials nationwide are urging Congress to increase the THC limit for hemp to one percent by dry weight. A researcher from the Department of Justice recently questioned the rationale behind the current 0.3 percent THC limit, suggesting it was arbitrarily based on a decades-old anecdote.


Advancements in Law Enforcement Procedures


The integration of novel testing methods heralds a significant shift in law enforcement strategies concerning cannabis-related cases. Crime lab forensic studies have advanced to a new level of paradigm with the use of the DART-HRMS method and the GC-MS technology developed by NIST. Law enforcement officers will be able to distinguish between marijuana and hemp with remarkable accuracy thanks to these state-of-the-art approaches, which promise increased precision and efficiency. By integrating these advanced technologies into routines for standard operating procedures and training, law enforcement organizations are providing their staff with the necessary resources to handle the complex terrain of changing cannabis laws.


This revolutionary method improves the ability to conduct investigations and makes it easier to comply with state and federal laws on cannabis. Law enforcement organizations may ensure compliance with the ever-changing legal framework pertaining to cannabis cultivation, distribution, and use while efficiently upholding justice with the use of these cutting-edge tactics. Officers will be better prepared to handle the issues raised by the legalization of cannabis and its effects on law enforcement procedures as they become used to these innovative techniques.


Legal and Regulatory Implications of Hemp Legalization


The legalization of hemp with THC levels of up to 0.3 percent under the 2018 Farm Bill has sparked significant legal and regulatory ramifications. This legislative shift has not only complicated cannabis-related cases but has also necessitated a reevaluation of existing law enforcement protocols. As prosecutors and law enforcement officials grapple with the distinction between marijuana and hemp, the landscape of criminal justice procedures undergoes notable evolution. The dismissal of numerous low-level cannabis cases in states like Texas following hemp legalization underscores the profound impact of this legislative change on law enforcement practices.


Furthermore, the proposal to raise hemp’s THC limitations to 1% of dry weight is indicative of continuing discussions about federal cannabis legislation. The debate over THC restrictions highlights the necessity for a nuanced approach to cannabis regulation as advocates for legislative changes, including agricultural officials and hemp sector players, are in favor of it. In the meanwhile, the Department of Justice’s examination of the present THC restriction of 0.3 percent emphasizes how crucial evidence-based policymaking is to determining how cannabis legislation will develop in the future. Stakeholders from a variety of industries must negotiate the tricky convergence of legal, scientific, and sociological factors surrounding the legalization of hemp as regulatory frameworks continue to change.


Bottom Line


The integration of novel cannabis testing methods, including DART-HRMS and GC-MS, marks a significant advancement in law enforcement’s ability to differentiate between marijuana and hemp, streamlining investigative procedures and ensuring compliance with evolving legal frameworks. These state-of-the-art technologies promise heightened precision and efficiency, empowering law enforcement agencies to navigate the complexities of cannabis-related cases with unprecedented accuracy. As debates surrounding THC limits and federal cannabis legislation persist, stakeholders must engage in evidence-based policymaking to shape the future of hemp regulation. By staying abreast of legal and regulatory developments, law enforcement agencies can adapt their procedures accordingly, ensuring justice is served while upholding compliance with the law, thus paving the way for more effective practices in the dynamic landscape of cannabis legalization.





Source link

Continue Reading


Copyright © 2021 The Art of MaryJane Media